4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001209191-22-011038
Options or other derivatives
- Chief Scientific Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Scherle Peggy Chief Scientific Officer | 2022-02-15 | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | D | ||
Loading xslF345X03/doc4.xml…